- Home
- PCRX vs AORT Comparison
PCRX vs AORT Comparison
Compare PCRX & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- AORT
- Stock Information
- Founded
- PCRX 2006
- AORT 1984
- Country
- PCRX United States
- AORT United States
- Employees
- PCRX N/A
- AORT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- AORT Medical/Dental Instruments
- Sector
- PCRX Health Care
- AORT Health Care
- Exchange
- PCRX Nasdaq
- AORT Nasdaq
- Market Cap
- PCRX 1.2B
- AORT 1.0B
- IPO Year
- PCRX 2011
- AORT 1993
- Fundamental
- Price
- PCRX $26.25
- AORT $28.80
- Analyst Decision
- PCRX Buy
- AORT Strong Buy
- Analyst Count
- PCRX 9
- AORT 5
- Target Price
- PCRX $29.89
- AORT $31.40
- AVG Volume (30 Days)
- PCRX 891.6K
- AORT 545.9K
- Earning Date
- PCRX 05-08-2025
- AORT 05-05-2025
- Dividend Yield
- PCRX N/A
- AORT N/A
- EPS Growth
- PCRX N/A
- AORT N/A
- EPS
- PCRX N/A
- AORT N/A
- Revenue
- PCRX $702,772,000.00
- AORT $390,084,000.00
- Revenue This Year
- PCRX $8.63
- AORT $12.18
- Revenue Next Year
- PCRX $11.66
- AORT $10.39
- P/E Ratio
- PCRX N/A
- AORT N/A
- Revenue Growth
- PCRX 3.08
- AORT 5.94
- 52 Week Low
- PCRX $11.16
- AORT $21.97
- 52 Week High
- PCRX $31.64
- AORT $32.33
- Technical
- Relative Strength Index (RSI)
- PCRX 49.37
- AORT 63.78
- Support Level
- PCRX $25.33
- AORT $28.07
- Resistance Level
- PCRX $26.44
- AORT $30.00
- Average True Range (ATR)
- PCRX 0.91
- AORT 0.59
- MACD
- PCRX -0.03
- AORT -0.08
- Stochastic Oscillator
- PCRX 61.96
- AORT 56.48
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.